Cancer BiologybioRxiv
A testosterone metabolite 19-hydroxyandrostenedione induces neuroendocrine trans-differentiation of prostate cancer cells via an ectopic olfactory receptor
T. Abaffy, J. R. Bain, M. J. Muehlbauer…·H. Matsunami
This study identifies 19-hydroxyandrostenedione as an endogenous agonist of OR51E2 that induces neuroendocrine trans-differentiation in prostate cancer cells.
DOI 10.3389/fonc.2018.00162